Wuhan Shengshi Tangren Hospital Investment Management Co., Ltd.

Shengshi Tangren Group (hereinafter referred to as the Group) was established in 2003. It is a modern enterprise group integrating pharmaceutical operations, hospital investment management, medical device sales, and media, among other businesses. It has 8 controlled enterprises and enjoys a high reputation in the industry. The Group is headquartered in Wuhan, a major industrial city in Central China known as the thoroughfare to nine provinces. It is located in Wujiashan Strait Entrepreneurship City, Dongxihu District, with convenient transportation and smooth logistics, covering an area of over 26,000 square meters and employing more than 1,000 people.
The Group has always focused on the private hospital market, which has great potential, and is committed to improving the profitability of private hospitals. From pharmaceutical supply to medical investment management, it provides private hospitals with comprehensive services such as pharmacy standardization, medical devices, and media. The Group's subsidiary, Hubei Tangren Pharmaceutical Co., Ltd., has a registered capital of 20 million yuan and passed GSP certification in one go in 2003. The company's products are mainly new products with independent intellectual property rights, supplemented by national general agency products. It operates more than 200 pharmaceutical varieties, mainly including antibiotics, antimicrobials, hepatitis B, gynecology, andrology, and miscellaneous drugs. The company combines self-built logistics networks with logistics outsourcing and has established a logistics sales and distribution network covering 26 provinces and cities nationwide.
While the pharmaceutical company continued to achieve brilliant results, the Group, based on the needs of its business strategy development, actively expanded its business scope and established Wuhan Shengshi Tangren Hospital Investment Management Co., Ltd. Following the hospital-running policy of "taking medical quality as the foundation, medical safety as the premise, technology as the guide, and brand management as the center," the company invested heavily to successively establish the East Branch of Yichang Changhang Hospital, and acquired six large and medium-sized general hospitals, including Yichang Changhang Hospital, Wuhan Xinte Traditional Chinese Medicine Hospital, Yingcheng Ren'ai Hospital, Zaoyang Taikang Hospital, Yichang Heping Hospital, and Wuhan Tangren Shengsheng Hospital. It is expected that in the next five years, it will continue to invest in dozens of large and medium-sized private hospitals. After taking over the hospitals, the company invested heavily in purchasing a large number of advanced medical equipment, introduced high-end medical and management talents with considerable professional quality, and applied a mature modern hospital management model. In less than a year, the turnover of each hospital steadily increased, enhancing both the economic and social benefits of the hospitals, contributing to the development of local health undertakings, and receiving unanimous recognition and praise from local governments, the public, and hospital employees.
In its future development, the Group will highlight four major effects: the scale development effect, brand radiation effect, talent aggregation effect, and value enhancement effect, so as to effectively allocate medical resources, continue exploring the path of group-based hospital management, establish a century-old Tangren brand, base itself in Hubei, radiate across the country, and build a business platform for group-based hospital operations. At the same time, it will look nationwide and even overseas, attracting a large number of outstanding R&D talents, management talents, and technical talents in the field of hospital management to continuously join, and through connection with the capital market, enhance the value of the hospital management group.
After ten years of hard work and brilliance, advancing with the times to write a magnificent chapter, Shengshi Tangren Group has gradually developed into a modern new medical group that focuses on building the Tangren brand system and architecture, cultivating the corporate culture of Yangzhonghuawei and shaping the Tangren soul, and is moving toward diversified operations.